Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 60Lung Neoplasms 38Melanoma 22Ovarian Neoplasms 20Breast Neoplasms 18Mesothelioma, Malignant 13Colorectal Neoplasms 13Pancreatic Neoplasms 12Neoplasm Metastasis 12Small Cell Lung Carcinoma 11Triple Negative Breast Neoplasms 10Carcinoma, Renal Cell 10Neoplasms 9Mesothelioma 9Stomach Neoplasms 8Sarcoma 8Thymoma 7Carcinoma, Hepatocellular 7Squamous Cell Carcinoma of Head and Neck 6Carcinoma, Merkel Cell 6Esophageal Neoplasms 5Carcinoma, Transitional Cell 5Adenocarcinoma of Lung 5Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Sarcoma, Synovial 4Multiple Myeloma 4Head and Neck Neoplasms 4Colonic Neoplasms 4Carcinoma, Ovarian Epithelial 4

Interventions

tucatinib 1pembrolizumab 1niraparib 1atezolizumab 1Trastuzumab 1Tissue Banks 1GSK-3326595 1Fulvestrant 1Etoposide 1Diet 1Cyclophosphamide 1Blood Specimen Collection 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Neoplasms × Cyclophosphamide × Thoracic × Clear all
NCT03420963 2026-03-20

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Terminated
12 enrolled
DermatologicGenitourinaryHead & NeckOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Bone Neoplasms, Endocrine Gland Neoplasms, Melanoma, Mouth Neoplasms, Pharyngeal Neoplasms, Sarcoma, Skin Neoplasms, Thyroid Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡